TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors

Abstract Background Perivascular epithelioid cell tumors (PEComas) rarely appear in the head and neck region. This case report describes two transcription factor E3 (TFE3)-rearranged PEComa cases, consisting of one in the orbit and one in the nasal cavity. Case presentation Both cases demonstrated s...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuka Takahashi, Akihiko Yoshida, Seiichi Yoshimoto, Shigenobu Suzuki, Satsuki Kishikawa, Ayaka Mitsui, Eijitsu Ryo, Yuki Kojima, Kan Yonemori, Yasushi Yatabe, Taisuke Mori
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Diagnostic Pathology
Subjects:
Online Access:https://doi.org/10.1186/s13000-025-01602-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595080228110336
author Yuka Takahashi
Akihiko Yoshida
Seiichi Yoshimoto
Shigenobu Suzuki
Satsuki Kishikawa
Ayaka Mitsui
Eijitsu Ryo
Yuki Kojima
Kan Yonemori
Yasushi Yatabe
Taisuke Mori
author_facet Yuka Takahashi
Akihiko Yoshida
Seiichi Yoshimoto
Shigenobu Suzuki
Satsuki Kishikawa
Ayaka Mitsui
Eijitsu Ryo
Yuki Kojima
Kan Yonemori
Yasushi Yatabe
Taisuke Mori
author_sort Yuka Takahashi
collection DOAJ
description Abstract Background Perivascular epithelioid cell tumors (PEComas) rarely appear in the head and neck region. This case report describes two transcription factor E3 (TFE3)-rearranged PEComa cases, consisting of one in the orbit and one in the nasal cavity. Case presentation Both cases demonstrated sheet-like or focal nested architecture and comprised epithelioid cells with abundant clear to eosinophilic cytoplasm and vascular stroma. The first case exhibited partial pleomorphism, a small necrosis area, and slightly increased mitosis and was classified as malignant. The second case demonstrated mild atypia and no mitosis or necrosis and was categorized as benign. The nasal tumor was initially considered a TFE3-rearranged renal cell carcinoma metastasis. However, a subsequent renal tumor biopsy revealed angiomyolipoma. The RNA sequence revealed ZC3H4::TFE3 and PRCC::TFE3 fusions in the first and second cases, respectively. Conclusion The fusion partner gene ZC3H4 is uncommon, and this is the third reported PEComa case. The fusion partner gene PRCC is often reported in TFE3-rearranged renal cell carcinoma, and this PEComa case is the second reported in the head and neck region. The initially reported cases with the fusion partner genes ZC3H4 and PRCC were categorized as malignant. These cases were discussed with a literature review.
format Article
id doaj-art-e5f6e485d91d47f69a9b83da635fb8cb
institution Kabale University
issn 1746-1596
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Diagnostic Pathology
spelling doaj-art-e5f6e485d91d47f69a9b83da635fb8cb2025-01-19T12:07:50ZengBMCDiagnostic Pathology1746-15962025-01-0120111010.1186/s13000-025-01602-9TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumorsYuka Takahashi0Akihiko Yoshida1Seiichi Yoshimoto2Shigenobu Suzuki3Satsuki Kishikawa4Ayaka Mitsui5Eijitsu Ryo6Yuki Kojima7Kan Yonemori8Yasushi Yatabe9Taisuke Mori10Department of Diagnostic Pathology, National Cancer Center HospitalDepartment of Diagnostic Pathology, National Cancer Center HospitalDepartment of Head and Neck Surgery, National Cancer Center HospitalDepartment of Ophthalmic Oncology, National Cancer Center HospitalDepartment of Diagnostic Pathology, National Cancer Center HospitalDepartment of Diagnostic Pathology, National Cancer Center HospitalDivision of Molecular Pathology, National Cancer Center Research InstituteDepartment of Medical Oncology, National Cancer Center HospitalDepartment of Medical Oncology, National Cancer Center HospitalDepartment of Diagnostic Pathology, National Cancer Center HospitalDepartment of Diagnostic Pathology, National Cancer Center HospitalAbstract Background Perivascular epithelioid cell tumors (PEComas) rarely appear in the head and neck region. This case report describes two transcription factor E3 (TFE3)-rearranged PEComa cases, consisting of one in the orbit and one in the nasal cavity. Case presentation Both cases demonstrated sheet-like or focal nested architecture and comprised epithelioid cells with abundant clear to eosinophilic cytoplasm and vascular stroma. The first case exhibited partial pleomorphism, a small necrosis area, and slightly increased mitosis and was classified as malignant. The second case demonstrated mild atypia and no mitosis or necrosis and was categorized as benign. The nasal tumor was initially considered a TFE3-rearranged renal cell carcinoma metastasis. However, a subsequent renal tumor biopsy revealed angiomyolipoma. The RNA sequence revealed ZC3H4::TFE3 and PRCC::TFE3 fusions in the first and second cases, respectively. Conclusion The fusion partner gene ZC3H4 is uncommon, and this is the third reported PEComa case. The fusion partner gene PRCC is often reported in TFE3-rearranged renal cell carcinoma, and this PEComa case is the second reported in the head and neck region. The initially reported cases with the fusion partner genes ZC3H4 and PRCC were categorized as malignant. These cases were discussed with a literature review.https://doi.org/10.1186/s13000-025-01602-9Perivascular epithelioid cell tumorTranscription factor E3Head and neckZC3H4PRCC
spellingShingle Yuka Takahashi
Akihiko Yoshida
Seiichi Yoshimoto
Shigenobu Suzuki
Satsuki Kishikawa
Ayaka Mitsui
Eijitsu Ryo
Yuki Kojima
Kan Yonemori
Yasushi Yatabe
Taisuke Mori
TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors
Diagnostic Pathology
Perivascular epithelioid cell tumor
Transcription factor E3
Head and neck
ZC3H4
PRCC
title TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors
title_full TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors
title_fullStr TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors
title_full_unstemmed TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors
title_short TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors
title_sort tfe3 rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners clues to the differential diagnosis between benign and malignant tumors
topic Perivascular epithelioid cell tumor
Transcription factor E3
Head and neck
ZC3H4
PRCC
url https://doi.org/10.1186/s13000-025-01602-9
work_keys_str_mv AT yukatakahashi tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors
AT akihikoyoshida tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors
AT seiichiyoshimoto tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors
AT shigenobusuzuki tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors
AT satsukikishikawa tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors
AT ayakamitsui tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors
AT eijitsuryo tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors
AT yukikojima tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors
AT kanyonemori tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors
AT yasushiyatabe tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors
AT taisukemori tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors